https://www.taylorcollison.com.au/wp-content/uploads/2021/07/IMM-20210706-Upgrade.pdf
Efti development program expanded
Our View
IMM has announced plans to expand the clinical program for efti funded by a $65m capital raise. Key additions are i) a Phase III trial of efti plus paclitaxel in metastatic breast cancer (mBC); and ii) a Phase II trial of efti/chemo/anti-PD1 triple combo in non-small cell lung cancer (NSCLC). The recent GSK/Iteos licence deal, which included US$625m upfront and total deal value over US$2bn for a Phase I TIGIT drug highlights the value big pharma attributes to promising immuno-oncology (IO) combo therapies, and indicates the potential value of efti if it demonstrates efficacy in the planned TACTI-003 randomised Phase IIb in head and neck cancer.
We revise our risk-adjusted valuation of IMM, adding the mBC Phase III (risked to 25%), updating the upfront and milestone payments from a potential efti licence deal in light of the GSK/iTeos deal and increasing modelled royalty rates. Our post cap raise valuation increases to $1,002m (vs $714m), $1.14/sh fully diluted (vs $1.00/sh) or $1.19/sh undiluted.
- Forums
- ASX - By Stock
- Ann: Immutep Capital Raising Presentation
https://www.taylorcollison.com.au/wp-content/uploads/2021/07/IMM-...
-
-
- There are more pages in this discussion • 71 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
39.0¢ |
Change
-0.005(1.27%) |
Mkt cap ! $566.5M |
Open | High | Low | Value | Volume |
39.0¢ | 39.8¢ | 38.5¢ | $1.972M | 5.027M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 76111 | 38.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
39.5¢ | 82464 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 76111 | 0.385 |
7 | 83926 | 0.380 |
1 | 8500 | 0.375 |
4 | 69756 | 0.370 |
2 | 32578 | 0.365 |
Price($) | Vol. | No. |
---|---|---|
0.395 | 82464 | 3 |
0.400 | 127450 | 6 |
0.405 | 218620 | 4 |
0.410 | 220354 | 7 |
0.415 | 201366 | 8 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |